ReviewCurrent hematologic malignancy reports2023

Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents.

Prateek Pophali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.